RESUMO
Plasmodium falciparum transmission-blocking vaccines (TBVs) targeting the Pfs25 antigen have shown promise in mice but the same efficacy has never been achieved in humans. We have previously published pre-clinical data related to a TBV candidate Pfs25-IMX313 encoded in viral vectors which was very promising and hence progressed to human clinical trials. The results from the clinical trial of this vaccine were very modest. Here we unravel why, contrary to mice, this vaccine has failed to induce robust antibody (Ab) titres in humans to elicit transmission-blocking activity. We examined Pfs25-specific B cell and T follicular helper (Tfh) cell responses in mice and humans after vaccination with Pfs25-IMX313 encoded by replication-deficient chimpanzee adenovirus serotype 63 (ChAd63) and the attenuated orthopoxvirus modified vaccinia virus Ankara (MVA) delivered in the heterologous prime-boost regimen via intramuscular route. We found that after vaccination, the Pfs25-IMX313 was immunologically suboptimal in humans compared to mice in terms of serum Ab production and antigen-specific B, CD4+ and Tfh cell responses. We identified that the key determinant for the poor anti-Pfs25 Ab formation in humans was the lack of CD4+ T cell recognition of Pfs25-IMX313 derived peptide epitopes. This is supported by correlations established between the ratio of proliferated antigen-specific CD4+/Tfh-like T cells, CXCL13 sera levels, and the corresponding numbers of circulating Pfs25-specific memory B cells, that consequently reflected on antigen-specific IgG sera levels. These correlations can inform the design of next-generation Pfs25-based vaccines for robust and durable blocking of malaria transmission.
Assuntos
Anticorpos Antiprotozoários/sangue , Linfócitos T CD4-Positivos/efeitos dos fármacos , Imunidade Humoral/efeitos dos fármacos , Imunogenicidade da Vacina , Vacinas Antimaláricas/administração & dosagem , Malária Falciparum/prevenção & controle , Plasmodium falciparum/imunologia , Proteínas de Protozoários/administração & dosagem , Proteínas Recombinantes/administração & dosagem , Adolescente , Adulto , Animais , Linfócitos B/efeitos dos fármacos , Linfócitos B/imunologia , Linfócitos B/parasitologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/parasitologia , Células Cultivadas , Modelos Animais de Doenças , Epitopos , Feminino , Humanos , Vacinas Antimaláricas/imunologia , Malária Falciparum/imunologia , Malária Falciparum/parasitologia , Malária Falciparum/transmissão , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Pessoa de Meia-Idade , Plasmodium falciparum/patogenicidade , Proteínas de Protozoários/imunologia , Proteínas Recombinantes/imunologia , Especificidade da Espécie , Vacinação , Adulto JovemRESUMO
All the time, echinococcosis is a global zoonotic disease which seriously endangers public health all over the world. In order to speed up the development process of anti-Echinococcus granulosus vaccine, at the same time, it can also save economic cost. In this study, immunoinformatics tools and molecular docking methods were used to predict and screen the antigen epitopes of Echinococcus granulosus, to design a multi-epitope vaccine containing B- and T-cell epitopes. The multi-epitope vaccine could activate B lymphocytes to produce specific antibodies theoretically, which could protect the human body against Echinococcus granulosus infection. It also could activate T lymphocytes and clear the infected parasites in the body. In this study, four CD8+ T-cell epitopes, three CD4+ T-cell epitopes and four B-cell epitopes of Protein EgTeg were identified by immunoinformatics methods. Meanwhile, three CD8+ T-cell epitopes, two CD4+ T-cell epitopes and four B-cell epitopes of Protein EgFABP1 were identified. We constructed the multi-epitope vaccine using linker proteins. The study based on the traditional methods of antigen epitope prediction, further optimized the prediction results combined with molecular docking technology and improved the precision and accuracy of the results. Finally, in vivo and in vitro experiments had verified that the vaccine designed in this study had good antigenicity and immunogenicity.
Assuntos
Antígenos de Helmintos/farmacologia , Desenho de Fármacos , Equinococose/prevenção & controle , Echinococcus granulosus/imunologia , Epitopos de Linfócito B/imunologia , Epitopos de Linfócito T/imunologia , Simulação de Acoplamento Molecular , Vacinas de DNA/farmacologia , Adolescente , Adulto , Animais , Anticorpos Anti-Helmínticos/sangue , Antígenos de Helmintos/imunologia , Linfócitos B/imunologia , Linfócitos B/parasitologia , Células Cultivadas , Desenho Assistido por Computador , Modelos Animais de Doenças , Equinococose/sangue , Equinococose/imunologia , Equinococose/parasitologia , Proteínas de Ligação a Ácido Graxo/imunologia , Proteínas de Ligação a Ácido Graxo/farmacologia , Humanos , Imunidade Humoral , Imunogenicidade da Vacina , Ativação Linfocitária , Camundongos Endogâmicos BALB C , Pessoa de Meia-Idade , Linfócitos T/imunologia , Linfócitos T/parasitologia , Vacinas de DNA/imunologia , Vacinas de Subunidades Antigênicas/imunologia , Vacinas de Subunidades Antigênicas/farmacologia , Adulto JovemRESUMO
Antibodies targeting the NANP/NVDP repeat domain of the Plasmodium falciparum circumsporozoite protein (CSPRepeat) can protect against malaria. However, it has also been suggested that the CSPRepeat is a decoy that prevents the immune system from mounting responses against other domains of CSP. Here, we show that, following parasite immunization, B cell responses to the CSPRepeat are immunodominant over responses to other CSP domains despite the presence of similar numbers of naive B cells able to bind these regions. We find that this immunodominance is driven by avid binding of the CSPRepeat to cognate B cells that are able to expand at the expense of B cells with other specificities. We further show that mice immunized with repeat-truncated CSP molecules develop responses to subdominant epitopes and are protected against malaria. These data demonstrate that the CSPRepeat functions as a decoy, but truncated CSP molecules may be an approach for malaria vaccination.
Assuntos
Anticorpos Antiprotozoários/biossíntese , Imunização/métodos , Vacinas Antimaláricas/administração & dosagem , Malária/prevenção & controle , Peptídeos/administração & dosagem , Plasmodium berghei/efeitos dos fármacos , Proteínas de Protozoários/genética , Animais , Anopheles/parasitologia , Anticorpos Neutralizantes/biossíntese , Linfócitos B/imunologia , Linfócitos B/parasitologia , Feminino , Expressão Gênica , Malária/imunologia , Malária/parasitologia , Vacinas Antimaláricas/biossíntese , Vacinas Antimaláricas/genética , Camundongos , Camundongos Endogâmicos C57BL , Peptídeos/genética , Peptídeos/imunologia , Plasmodium berghei/imunologia , Plasmodium berghei/patogenicidade , Plasmodium falciparum/efeitos dos fármacos , Plasmodium falciparum/imunologia , Plasmodium falciparum/patogenicidade , Ligação Proteica , Proteínas de Protozoários/imunologia , Esporozoítos/imunologia , Esporozoítos/efeitos da radiação , Transgenes , Vacinas AtenuadasRESUMO
Malaria is a potentially life-threatening disease with approximately half of the world's population at risk. Young children and pregnant women are hit hardest by the disease. B cells and antibodies are part of an adaptive immune response protecting individuals continuously exposed to the parasite. An infection with Plasmodium falciparum can cause dysregulation of B cell homeostasis, while antibodies are known to be key in controlling symptoms and parasitemia. BAFF is an instrumental cytokine for the development and maintenance of B cells. Pregnancy alters the immune status and renders previously clinically immune women at risk of severe malaria, potentially due to altered B cell responses associated with changes in BAFF levels. In this prospective study, we investigated the levels of BAFF in a malaria-endemic area in mothers and their infants from birth up to 9 months. We found that BAFF-levels are significantly higher in infants than in mothers. BAFF is highest in cord blood and then drops rapidly, but remains significantly higher in infants compared to mothers even at 9 months of age. We further correlated BAFF levels to P. falciparum-specific antibody levels and B cell frequencies and found a negative correlation between BAFF and both P. falciparum-specific and total proportions of IgG+ memory B cells, as well as CD27- memory B cells, indicating that exposure to both malaria and other diseases affect the development of B-cell memory and that BAFF plays a part in this. In conclusion, we have provided new information on how natural immunity against malaria is formed.
Assuntos
Fator Ativador de Células B/sangue , Malária Falciparum/sangue , Anticorpos Antiprotozoários/sangue , Anticorpos Antiprotozoários/imunologia , Fator Ativador de Células B/imunologia , Linfócitos B/imunologia , Linfócitos B/parasitologia , Feminino , Humanos , Lactente , Estudos Longitudinais , Malária Falciparum/imunologia , Mães , Plasmodium falciparum/imunologia , Plasmodium falciparum/isolamento & purificação , Gravidez , Estudos Prospectivos , UgandaRESUMO
Parasites of the genus Leishmania cause the disease leishmaniasis. As the sandfly vector transfers the promastigotes into the skin of the human host, the infection is either cured or exacerbated. In the process, there emerge several unsolved paradoxes of leishmaniasis. Chronologically, as the infections starts in skin, the role of the salivary proteins in supporting the infection or the host response to these proteins influencing the induction of immunological memory becomes a conundrum. As the parasite invokes inflammation, the infiltrating neutrophils may act as "Trojan Horse" to transfer parasites to macrophages that, along with dendritic cells, carry the parasite to lymphoid organs to start visceralization. As the visceralized infection becomes chronic, the acutely enhanced monocytopoiesis takes a downturn while neutropenia and thrombocytopenia ensue with concomitant rise in splenic colony-forming-units. These responses are accompanied by splenic and hepatic granulomas, polyclonal activation of B cells and deviation of T cell responses. The granuloma formation is both a containment process and a form of immunopathogenesis. The heterogeneity in neutrophils and macrophages contribute to both cure and progression of the disease. The differentiation of T-helper subsets presents another paradox of visceral leishmaniasis, as the counteractive T cell subsets influence the curing or non-curing outcome. Once the parasites are killed by chemotherapy, in some patients the cured visceral disease recurs as a cutaneous manifestation post-kala azar dermal leishmaniasis (PKDL). As no experimental model exists, the natural history of PKDL remains almost a black box at the end of the visceral disease.
Assuntos
Leishmania/imunologia , Leishmaniose Cutânea/imunologia , Leishmaniose Visceral/imunologia , Animais , Linfócitos B/imunologia , Linfócitos B/parasitologia , Humanos , Leishmaniose Cutânea/parasitologia , Leishmaniose Visceral/parasitologia , Macrófagos/imunologia , Macrófagos/parasitologia , Pele/imunologia , Pele/parasitologia , Subpopulações de Linfócitos T/imunologia , Subpopulações de Linfócitos T/parasitologiaRESUMO
We have previously shown that a variant of the TNFSF13B gene that we called BAFF-var increases the production of the cytokine BAFF, upregulating humoral immunity and increasing the risk for certain autoimmune diseases. In addition, genetic population signatures revealed that BAFF-var was evolutionarily advantageous, most likely by increasing resistance to malaria infection, which is a prime candidate for selective pressure. To evaluate whether the increased soluble BAFF (sBAFF) production confers protection, we experimentally assessed the role of BAFF-var in response to malaria antigens. Lysates of erythrocytes infected with Plasmodium falciparum (iRBCs) or left uninfected (uRBCs, control) were used to treat peripheral blood mononuclear cells (PBMCs) with distinct BAFF genotypes. The PBMCs purified from BAFF-var donors and treated with iRBCs showed different levels of specific cells, immunoglobulins, and cytokines as compared with BAFF-WT. In particular, a relevant differential effect on mucosal immunity B subpopulations have been observed. These findings point to specific immune cells and molecules through which the evolutionary selected BAFF-var may have improved fitness during P. falciparum infection.
Assuntos
Fator Ativador de Células B/metabolismo , Linfócitos B/metabolismo , Eritrócitos/parasitologia , Evolução Molecular , Imunidade nas Mucosas , Malária Falciparum/metabolismo , Plasmodium falciparum/patogenicidade , Adulto , Idoso , Idoso de 80 Anos ou mais , Fator Ativador de Células B/genética , Linfócitos B/imunologia , Linfócitos B/parasitologia , Células Cultivadas , Feminino , Aptidão Genética , Genótipo , Interações Hospedeiro-Parasita , Humanos , Itália , Malária Falciparum/sangue , Malária Falciparum/genética , Malária Falciparum/parasitologia , Masculino , Pessoa de Meia-Idade , Fenótipo , Regulação para CimaRESUMO
This study aimed to establish a pure single-cell Theileria annulata-infected B cell line for the assessment of cytokine production in transformed and lipopolysaccharide (LPS)-stimulated cells. Several studies have aimed to identify cell surface markers in T. annulata-transformed cells; however, no information on cytokine production in these cells is available. To investigate the potential of the transformed cells to produce cytokines and their potential responses to antigen-stimulation, we purified mature B cells (CD21) from the whole blood of cattle experimentally infected with the T. annulata Kashi strain by magnetic separation. The purity and specificity of the established cell line was assessed by the identification of specific cell surface markers (CD21, IgM, and WC4) by flow cytometry analysis. The transcript levels of the cytokines IL1A, IL1B, IL2, IL4, IL6, IL8, IL10, IL16, LTA, TGFB1, TNFA, IFNA, and IFNB in transformed, buparvaquone (BW720c)-treated cells, and antigen-stimulated cells were analyzed by quantitative polymerase chain reaction (qPCR) using cDNA from these cells. A T. annulata-infected bovine B cell line was successfully established with a purity of ~98.8% (CD21). IL4 and IL12A were significantly (p < 0.01) upregulated in the transformed cells. In BW720c-treated transformed cells, IL12B, TGFB1, and IFNB were significantly (p < 0.01) upregulated. Notably, no significant (p > 0.05) upregulation of cytokines was observed in LPS-stimulated transformed cells. Moreover, IL1A, IL1B, IL8, and IL16 were significantly (p < 0.01) upregulated in LPS-stimulated B cells. Our data signify the potential use of this cell line for cytokine production, observance of immunoglobulins, and production of an attenuated vaccine against tropical theileriosis.
Assuntos
Linfócitos B/metabolismo , Citocinas/genética , Theileria annulata/efeitos dos fármacos , Theileriose/genética , Animais , Antígenos/genética , Antígenos/imunologia , Linfócitos B/efeitos dos fármacos , Linfócitos B/parasitologia , Bovinos , Citocinas/classificação , Citometria de Fluxo , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Lipopolissacarídeos/farmacologia , Macrófagos/metabolismo , Macrófagos/parasitologia , Naftoquinonas/farmacologia , Análise de Célula Única , Theileria annulata/patogenicidade , Theileriose/sangue , Theileriose/parasitologiaRESUMO
Lymphatic filariasis, a chronic disfiguring disease exhibits complex pathology. Based on different clinical manifestations, infected individuals are categorized into asymptomatic-carriers and chronic-patients. The mechanism behind differential clinical outcomes remains unclear. Roles of filaria-specific B cell responses in filariasis have been documented, whereas the contribution of B1 cell response and poly-specific IgG and IgA in the context of clinical filariasis is not deciphered. In this study, we measured the poly-specific IgG and IgA levels in different clinical categories of filariasis. Asymptomatic-carriers exhibited increased IgG4 antibodies against both filarial-antigens as well as auto-antigens compared to other clinical categories, although IgG against these auto-antigens remained lower. IgA levels against both filarial and auto-antigens were decreased in asymptomatic-carriers. A positive correlation between anti-filarial IgG4 and IgG4 against auto-antigens were observed, suggesting the synergistic role of poly-specific natural IgG4 with anti-filarial IgG4 in blocking the pathogenesis in asymptomatic microfilarial cases.
Assuntos
Anticorpos Anti-Helmínticos/genética , Autoanticorpos/genética , Autoantígenos/genética , Filariose Linfática/imunologia , Imunoglobulina A/genética , Imunoglobulina G/genética , Wuchereria bancrofti/imunologia , Actinas/genética , Actinas/imunologia , Adulto , Animais , Anticorpos Anti-Helmínticos/sangue , Antígenos de Helmintos/sangue , Antígenos de Helmintos/genética , Doenças Assintomáticas , Autoanticorpos/sangue , Autoantígenos/imunologia , Linfócitos B/imunologia , Linfócitos B/parasitologia , DNA de Cadeia Simples/genética , DNA de Cadeia Simples/imunologia , Filariose Linfática/genética , Filariose Linfática/parasitologia , Filariose Linfática/patologia , Feminino , Expressão Gênica , Humanos , Imunoglobulina A/sangue , Imunoglobulina G/sangue , Masculino , Pessoa de Meia-Idade , Miosinas/genética , Miosinas/imunologia , Índice de Gravidade de Doença , Wuchereria bancrofti/patogenicidadeRESUMO
Protective immunity to blood-stage malaria is attributed to Plasmodium-specific IgG and effector-memory T helper 1 (Th1) cells. However, mice lacking the costimulatory receptor CD28 (CD28KO) maintain chronic parasitemia at low levels and do not succumb to infection, suggesting that other immune responses contribute to parasite control. We report here that CD28KO mice develop long-lasting non-sterile immunity and survive lethal parasite challenge. This protection correlated with a progressive increase of anti-parasite IgM serum levels during chronic infection. Serum IgM from chronically infected CD28KO mice recognize erythrocytes infected with mature parasites, and effectively control Plasmodium infection by promoting parasite lysis and uptake. These antibodies also recognize autoantigens and antigens from other pathogens. Chronically infected CD28KO mice have high numbers of IgM+ plasmocytes and experienced B cells, exhibiting a germinal-center independent Fas+GL7-CD38+CD73- phenotype. These cells are also present in chronically infected C57BL/6 mice although in lower numbers. Finally, IgM+ experienced B cells from cured C57BL/6 and CD28KO mice proliferate and produce anti-parasite IgM in response to infected erythrocytes. This study demonstrates that CD28 deficiency results in the generation of germinal-center independent IgM+ experienced B cells and the production of protective IgM during experimental malaria, providing evidence for an additional mechanism by which the immune system controls Plasmodium infection.
Assuntos
Antígenos CD28/genética , Imunoglobulina M/imunologia , Malária/genética , Plasmodium chabaudi/imunologia , 5'-Nucleotidase/genética , ADP-Ribosil Ciclase 1/genética , Animais , Anticorpos Antiprotozoários/genética , Anticorpos Antiprotozoários/imunologia , Antígenos de Diferenciação/genética , Linfócitos B/imunologia , Linfócitos B/parasitologia , Antígenos CD28/deficiência , Antígenos CD28/imunologia , Linfócitos T CD4-Positivos/imunologia , Eritrócitos/parasitologia , Centro Germinativo/imunologia , Centro Germinativo/parasitologia , Imunoglobulina G/genética , Imunoglobulina G/imunologia , Imunoglobulina M/sangue , Malária/sangue , Malária/imunologia , Malária/parasitologia , Camundongos , Camundongos Knockout , Plasmodium chabaudi/patogenicidade , Receptor fas/genéticaRESUMO
Reticulocyte-binding homologues (RH) are a ligand family that mediates merozoite invasion of erythrocytes in Plasmodium falciparum. Among the five members of this family identified so far, only P. falciparum reticulocyte-binding homologue-5 (PfRH5) has been found to be essential for parasite survival across strains that differ in virulence and route of host-cell invasion. Based on its essential role in invasion and early evidence of sequence conservation, PfRH5 has been prioritized for development as a vaccine candidate. However, little is known about the extent of genetic variability of RH5 in the field and the potential impact of such diversity on clinical outcomes or on vaccine evasion. Samples collected during a prospective cohort study of malaria incidence conducted in Kalifabougou, in southwestern Mali, were used to estimate genetic diversity, measure haplotype prevalence, and assess the within-host dynamics of PfRH5 variants over time and in relation to clinical malaria. A total of 10 nonsynonymous polymorphic sites were identified in the Pfrh5 gene, resulting in 13 haplotypes encoding unique protein variants. Four of these variants have not been previously observed. Plasmodium falciparum reticulocyte-binding homologue-5 had low amino acid haplotype (h = 0.58) and nucleotide (π = 0.00061) diversity. By contrast to other leading blood-stage malaria vaccine candidate antigens, amino acid differences were not associated with changes in the risk of febrile malaria in consecutive infections. Conserved B- and T-cell epitopes were identified. These results support the prioritization of PfRH5 for possible inclusion in a broadly cross-protective vaccine.
Assuntos
Proteínas de Transporte/genética , Epitopos de Linfócito B/imunologia , Epitopos de Linfócito T/imunologia , Haplótipos , Malária Falciparum/epidemiologia , Plasmodium falciparum/genética , Polimorfismo Genético , Adolescente , Adulto , Sequência de Aminoácidos , Linfócitos B/imunologia , Linfócitos B/parasitologia , Proteínas de Transporte/imunologia , Criança , Pré-Escolar , Epitopos de Linfócito B/genética , Epitopos de Linfócito T/genética , Eritrócitos/parasitologia , Feminino , Expressão Gênica , Humanos , Lactente , Vacinas Antimaláricas/biossíntese , Vacinas Antimaláricas/imunologia , Malária Falciparum/imunologia , Malária Falciparum/prevenção & controle , Masculino , Mali/epidemiologia , Peptídeos/química , Peptídeos/genética , Peptídeos/imunologia , Plasmodium falciparum/imunologia , Estudos Prospectivos , Linfócitos T/imunologia , Linfócitos T/parasitologiaRESUMO
BACKGROUND: Visceral leishmaniasis (VL) is a neglected tropical disease (NTD), caused by the intracellular protozoan parasites Leishmania donovani and Leishmania infantum. Symptomatic VL is considered fatal when left untreated. At present, there is no effective vaccine licensed for human use and available chemotherapies have limitations. Understanding the local immune mechanisms required for the control of infection is a key factor for developing effective vaccines and therapeutics. METHODS: We have investigated the development of the typical granulomatous lesions in the liver in experimental VL over time, together with the local immune responses. BALB/c mice were infected intravenously with a dose of 2 × 107 L. donovani amastigotes (MHOM/ET/67/HU3) and sacrificed at 15, 35 and 63 days post-infection (dpi). Histopathology and immunohistochemical techniques were used for the detection of Leishmania antigen, selected cell types including B and T lymphocytes, macrophages and neutrophils (CD45R-B220+, CD3+, F4/80+ and Ly-6G+) and iNOS. RESULTS: Granulomatous lesions were identified as early as 15 dpi in the livers of all infected animals. Three categories were used to classify liver granulomas (immature, mature and clear). Clear granulomas were exclusively detected from 35 dpi onwards. Kupffer cells (F4/80+) were predominant in immature granulomas, regardless of the dpi. Nonetheless, the highest expression was found 63 dpi. Positive staining for iNOS was mainly observed in the cytoplasm of fused Kupffer cells and the highest expression observed at 35 dpi. T cells (CD3+) and B cells (CD45R-B220+) were predominant in more advanced granuloma stages, probably related to the establishment of acquired immunity. Neutrophils (Ly-6G+) were predominantly observed in mature granulomas with the highest expression at 15 dpi. Neutrophils were lower in numbers compared to other cell types, particularly at later time points. CONCLUSIONS: Our results reflect the role of macrophages during the early stage of infection and the establishment of a lymphocytic response to control the infection in more advanced stages.
Assuntos
Granuloma/patologia , Leishmania donovani/fisiologia , Leishmania infantum/fisiologia , Leishmaniose Visceral/patologia , Hepatopatias/patologia , Animais , Linfócitos B/imunologia , Linfócitos B/parasitologia , Feminino , Granuloma/imunologia , Granuloma/parasitologia , Histologia , Humanos , Imuno-Histoquímica , Leishmaniose Visceral/imunologia , Leishmaniose Visceral/parasitologia , Fígado/imunologia , Fígado/parasitologia , Fígado/patologia , Hepatopatias/imunologia , Hepatopatias/parasitologia , Macrófagos/imunologia , Macrófagos/parasitologia , Camundongos , Camundongos Endogâmicos BALB C , Linfócitos T/imunologia , Linfócitos T/parasitologiaRESUMO
The histozoic myxozoan parasite Kudoa thyrsites causes postmortem myoliquefaction and is responsible for economic losses to salmon aquaculture in the Pacific Northwest. Despite its importance, little is known about the host-parasite relationship, including the host response to infection. The present work sought to characterize the immune response in Atlantic salmon during infection, recovery, and reexposure to K. thyrsites After exposure to infective seawater, infected and uninfected smolts were sampled three times over 4,275 degree-days. Histological analysis revealed infection severity decreased over time in exposed fish, while in controls there was no evidence of infection. Following a secondary exposure of all fish, severity of infection in the controls was similar to that measured in exposed fish at the first sampling time but was significantly reduced in reexposed fish, suggesting the acquisition of protective immunity. Using immunohistochemistry, we detected a population of MHIIß+ cells in infected muscle that followed a pattern of abundance concordant with parasite prevalence. Infiltration of these cells into infected myocytes preceded destruction of the plasmodium and dissemination of myxospores. Dual labeling indicated a majority of these cells were CD83+/MHIIß+ Using reverse transcription-quantitative PCR, we detected significant induction of cellular effectors, including macrophage/dendritic cells (mhii/cd83/mcsf), B cells (igm/igt), and cytotoxic T cells (cd8/nkl), in the musculature of infected fish. These data support a role for cellular effectors such as antigen-presenting cells (monocyte/macrophage and dendritic cells) along with B and T cells in the acquired protective immune response of Atlantic salmon against K. thyrsites.
Assuntos
Imunidade Adaptativa/imunologia , Células Apresentadoras de Antígenos/imunologia , Antígenos CD/imunologia , Imunoglobulinas/imunologia , Glicoproteínas de Membrana/imunologia , Myxozoa/imunologia , Salmo salar/imunologia , Salmo salar/parasitologia , Salmão/imunologia , Salmão/parasitologia , Animais , Células Apresentadoras de Antígenos/parasitologia , Aquicultura/métodos , Linfócitos B/imunologia , Linfócitos B/parasitologia , Células Dendríticas/imunologia , Células Dendríticas/parasitologia , Doenças dos Peixes/imunologia , Doenças dos Peixes/parasitologia , Interações Hospedeiro-Parasita/imunologia , Macrófagos/imunologia , Macrófagos/parasitologia , Células Musculares/imunologia , Células Musculares/parasitologia , Músculo Esquelético/imunologia , Músculo Esquelético/parasitologia , Doenças Parasitárias em Animais/imunologia , Doenças Parasitárias em Animais/parasitologia , Linfócitos T/imunologia , Linfócitos T/parasitologia , Antígeno CD83RESUMO
Lineage-Sca-1+c-Kit- (LSK-) cells are a lymphoid progenitor population that expands in the spleen and preferentially differentiates into mature B cells in response to Plasmodium yoelii infection in mice. Furthermore, LSK- derived B cells can subsequently contribute to the ongoing immune response through the generation of parasite-specific Ab-secreting cells, as well as germinal center and memory B cells. However, the factors that promote their differentiation into B cells in the spleen postinfection are not defined. In this article, we show that LSK- cells produce the cytokine IL-17 in response to Plasmodium infection. Using Il-17ra-/- mice, IL-17R signaling in cells other than LSK- cells was found to support their differentiation into B cells. Moreover, primary splenic stromal cells grown in the presence of IL-17 enhanced the production of CXCL12, a chemokine associated with B cell development in the bone marrow, by a population of IL-17RA-expressing podoplanin+CD31- stromal cells, a profile associated with fibroblastic reticular cells. Subsequent blockade of CXCL12 in vitro reduced differentiation of LSK- cells into B cells, supporting a direct role for this chemokine in this process. Immunofluorescence indicated that podoplanin+ stromal cells in the red pulp were the primary producers of CXCL12 after P. yoelii infection. Furthermore, podoplanin staining on stromal cells was more diffuse, and CXCL12 staining was dramatically reduced in Il-17ra-/- mice postinfection. Together, these results identify a distinct pathway that supports lymphoid development in the spleen during acute Plasmodium infection.
Assuntos
Células Produtoras de Anticorpos/fisiologia , Linfócitos B/fisiologia , Interleucina-17/metabolismo , Células Progenitoras Linfoides/fisiologia , Malária/imunologia , Plasmodium yoelii/imunologia , Baço/imunologia , Animais , Anticorpos Antiprotozoários/metabolismo , Células Produtoras de Anticorpos/parasitologia , Linfócitos B/parasitologia , Diferenciação Celular , Células Cultivadas , Quimiocina CXCL12/metabolismo , Feminino , Humanos , Memória Imunológica , Células Progenitoras Linfoides/parasitologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas Proto-Oncogênicas pp60(c-src)/metabolismo , Receptores de Interleucina-17/genéticaRESUMO
A geographical and causal connection has long been recognized between malaria, Epstein-Barr virus (EBV) infection and Burkitt's lymphoma (BL), but the underlying mechanisms remain obscure. Potential clues are that the malaria parasite Plasmodium falciparum selectively absorbs vitamin A from the host and depends on it for its biological activities; secondly, alterations in vitamin A (retinoid) metabolism have been implicated in many forms of cancer, including BL. The first author has proposed that the merozoite-stage malaria parasite, emerging from the liver, uses its absorbed vitamin A as a cell membrane destabilizer to invade the red blood cells, causing anemia and other signs and symptoms of the disease as manifestations of an endogenous form of hypervitaminosis A (Mawson AR, Path Global Health 2013;107(3):122-9). Repeated episodes of malaria would therefore be expected to expose the tissues of affected individuals to potentially toxic doses of vitamin A. It is proposed that such episodes activate latent EBV infection, which in turn activates retinoid-responsive genes. Expression of these genes enhances viral replication and induces germinal center (GC) B cell expansion, activation-induced cytidine deaminase (AID) expression, and c-myc translocation, which in turn predisposes to BL. Thus, an endogenous form of retinoid toxicity related to malaria infection may be the common factor linking frequent malaria, EBV infection and BL, whereby prolonged exposure of lymphatic tissues to high concentrations of retinoids may combine to induce B-cell translocation and increase the risk of Burkitt's lymphoma.
Assuntos
Linfoma de Burkitt/parasitologia , Linfoma de Burkitt/virologia , Infecções por Vírus Epstein-Barr/metabolismo , Malária Falciparum/metabolismo , Linfócitos B/metabolismo , Linfócitos B/parasitologia , Linfócitos B/patologia , Linfócitos B/virologia , Linfoma de Burkitt/complicações , Linfoma de Burkitt/metabolismo , Infecções por Vírus Epstein-Barr/complicações , Infecções por Vírus Epstein-Barr/virologia , Herpesvirus Humano 4/patogenicidade , Humanos , Malária Falciparum/complicações , Malária Falciparum/parasitologia , Malária Falciparum/virologia , Plasmodium falciparum/patogenicidade , Vitamina A/metabolismoRESUMO
Analysis of immunoglobulin (Ig) repertoires aims to comprehend Ig diversity with the goal of predicting humoral immune responses in the context of infection, vaccination, autoimmunity, and malignancies. The first next-generation sequencing (NGS) analyses of bulk B cell populations dramatically advanced sampling depth over previous low-throughput single-cell-based protocols, albeit at the expense of accuracy and loss of chain-pairing information. In recent years the field has substantially differentiated, with bulk analyses becoming more accurate while single-cell approaches have gained in throughput. Additionally, new platforms striving to combine high throughput and chain pairing have been developed as well as various computational tools for analysis. Here we review the developments of the past 4-5 years and discuss the open challenges.
Assuntos
Anticorpos/genética , Linfócitos B/imunologia , Doenças Transmissíveis/imunologia , Genes de Imunoglobulinas , Imunidade Humoral , Switching de Imunoglobulina , Alelos , Animais , Anticorpos/classificação , Doenças Autoimunes/genética , Doenças Autoimunes/prevenção & controle , Linfócitos B/microbiologia , Linfócitos B/parasitologia , Linfócitos B/virologia , Doenças Transmissíveis/microbiologia , Doenças Transmissíveis/parasitologia , Doenças Transmissíveis/virologia , Expressão Gênica , Variação Genética , Sequenciamento de Nucleotídeos em Larga Escala/métodos , Sequenciamento de Nucleotídeos em Larga Escala/estatística & dados numéricos , Humanos , Neoplasias/imunologia , Neoplasias/prevenção & controle , Análise de Célula Única/instrumentação , Análise de Célula Única/métodos , Vacinação , Vacinas/administração & dosagem , Vacinas/biossínteseRESUMO
Monoclonal antibody technologies have enabled dramatic advances in immunology, the study of infectious disease, and modern medicine over the past 40years. However, many monoclonal antibody discovery procedures are labor- and time-intensive, low efficiency, and expensive. Here we describe an optimized mAb discovery platform for the rapid and efficient isolation, cloning and characterization of monoclonal antibodies in murine systems. In this platform, antigen-binding splenic B cells from immunized mice are isolated by FACS and cocultured with CD40L positive cells to induce proliferation and mAb production. After 12days of coculture, cell culture supernatants are screened for antigen, and IgG positivity and RNA is isolated for reverse-transcription. Positive-well cDNA is then amplified by PCR and the resulting amplicons can be cloned into ligation-independent expression vectors, which are then used directly to transfect HEK293 cells for recombinant antibody production. After 4days of growth, conditioned medium can be screened using biolayer interferometry for antigen binding and affinity measurements. Using this method, we were able to isolate six unique, functional monoclonal antibodies against an antigen of the human malaria parasite Plasmodium falciparum. Importantly, this method incorporates several important advances that circumvent the need for single-cell PCR, restriction cloning, and large scale protein production, and can be applied to a wide array of protein antigens.
Assuntos
Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/isolamento & purificação , Antígenos/imunologia , Linfócitos B/imunologia , Células Clonais/imunologia , Clonagem Molecular/métodos , Vacinas Antimaláricas/imunologia , Vacinas Antimaláricas/isolamento & purificação , Plasmodium falciparum/imunologia , Proteínas de Protozoários/imunologia , Regiões 5' não Traduzidas , Animais , Anticorpos Monoclonais/biossíntese , Anticorpos Monoclonais/genética , Formação de Anticorpos , Especificidade de Anticorpos , Antígenos/administração & dosagem , Linfócitos B/parasitologia , Ligante de CD40/imunologia , Proliferação de Células , Separação Celular/métodos , Células Clonais/parasitologia , Técnicas de Cocultura , Citometria de Fluxo , Células HEK293 , Humanos , Imunização , Ativação Linfocitária , Vacinas Antimaláricas/biossíntese , Vacinas Antimaláricas/genética , Camundongos Endogâmicos BALB C , Reação em Cadeia da Polimerase , Proteínas de Protozoários/administração & dosagem , Fluxo de TrabalhoRESUMO
Malaria remains a major challenge to global health causing extensive morbidity and mortality. Yet, there is no efficient vaccine and the immune response remains incompletely understood. Apical Membrane Antigen 1 (AMA1), a leading vaccine candidate, plays a key role during merozoite invasion into erythrocytes by interacting with Rhoptry Neck Protein 2 (RON2). We generated a human anti-AMA1-antibody (humAbAMA1) by EBV-transformation of sorted B-lymphocytes from a Ghanaian donor and subsequent rescue of antibody variable regions. The antibody was expressed in Nicotiana benthamiana and in HEK239-6E, characterized for binding specificity and epitope, and analyzed for its inhibitory effect on Plasmodium falciparum. The generated humAbAMA1 shows an affinity of 106-135 pM. It inhibits the parasite strain 3D7A growth in vitro with an expression system-independent IC50-value of 35 µg/ml (95% confidence interval: 33 µg/ml-37 µg/ml), which is three to eight times lower than the IC50-values of inhibitory antibodies 4G2 and 1F9. The epitope was mapped to the close proximity of the RON2-peptide binding groove. Competition for binding between the RON2-peptide and humAbAMA1 was confirmed by surface plasmon resonance spectroscopy measurements. The particularly advantageous inhibitory activity of this fully human antibody might provide a basis for future therapeutic applications.
Assuntos
Anticorpos Monoclonais/imunologia , Antígenos de Protozoários/imunologia , Eritrócitos/parasitologia , Proteínas de Membrana/imunologia , Plasmodium falciparum/imunologia , Proteínas de Protozoários/imunologia , Linfócitos B/parasitologia , Ligação Competitiva , Linhagem Celular , Epitopos/imunologia , Eritrócitos/imunologia , Humanos , Imunoglobulina G/imunologia , Concentração Inibidora 50 , Leucócitos Mononucleares/parasitologia , Conformação Molecular , Ligação Proteica , Ressonância de Plasmônio de Superfície , NicotianaRESUMO
Theileria annulata is a tick-borne intracellular protozoan parasite that causes tropical theileriosis, a fatal bovine lymphoproliferative disease. The parasite predominantly invades bovine B lymphocytes and macrophages and induces host cell transformation by a mechanism that is not fully comprehended. Analysis of signaling pathways by quantitative real-time PCR (qPCR) could be a highly efficient means to understand this transformation mechanism. However, accurate analysis of qPCR data relies on selection of appropriate reference genes for normalization, yet few papers on T. annulata contain evidence of reference gene validation. We therefore used the geNorm and NormFinder programs to evaluate the stability of 5 candidate reference genes; 18S rRNA, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ACTB (ß-actin), PRKG1 (protein kinase cGMP-dependent, type I) and TATA box binding protein (TBP). The results showed that 18S rRNA was the reference gene most stably expressed in bovine PBMCs transformed and non-transformed with T. annulata, followed by GAPDH and TBP. While 18S rRNA and GAPDH were the best combination, these 2 genes were chosen as references to study signaling pathways involved in the transformation mechanism of T. annulata.
Assuntos
Células/parasitologia , Interações Hospedeiro-Parasita/genética , Reação em Cadeia da Polimerase em Tempo Real/veterinária , Transdução de Sinais/genética , Theileriose/fisiopatologia , Animais , Linfócitos B/parasitologia , Bovinos , Linhagem Celular , Células Cultivadas , Perfilação da Expressão Gênica , Reprodutibilidade dos Testes , Theileria annulata/fisiologiaRESUMO
Toxoplasma gondii is a widespread parasite responsible for causing clinical diseases especially in pregnant and immunosuppressed individuals. Glucocorticoid-induced TNF receptor (GITR), which is also known as TNFRS18 and belongs to the TNF receptor superfamily, is found to be expressed in various cell types of the immune system and provides an important costimulatory signal for T cells and myeloid cells. However, the precise role of this receptor in the context of T. gondii infection remains elusive. Therefore, the current study investigated the role of GITR activation in the immunoregulation mechanisms induced during the experimental infection of mice with T. gondii. Our data show that T. gondii infection slightly upregulates GITR expression in Treg cells and B cells, but the most robust increment in expression was observed in macrophages and dendritic cells. Interestingly, mice infected and treated with an agonistic antibody anti-GITR (DTA-1) presented a robust increase in pro-inflammatory cytokine production at preferential sites of parasite replication, which was associated with the decrease in latent brain parasitism of mice under treatment with DTA-1. Several in vivo and in vitro analysis were performed to identify the cellular mechanisms involved in GITR activation upon infection, however no clear alterations were detected in the phenotype/function of macrophages, Tregs and B cells under treatment with DTA-1. Therefore, GITR appears as a potential target for intervention during infection by the parasite Toxoplasma gondii, even though further studies are still necessary to better characterize the immune response triggered by GITR activation during T. gondii infection.
Assuntos
Linfócitos B/imunologia , Proteína Relacionada a TNFR Induzida por Glucocorticoide/imunologia , Células Mieloides/imunologia , Linfócitos T Reguladores/imunologia , Toxoplasma/imunologia , Toxoplasmose/imunologia , Animais , Anticorpos Neutralizantes/imunologia , Anticorpos Neutralizantes/farmacologia , Linfócitos B/parasitologia , Feminino , Proteína Relacionada a TNFR Induzida por Glucocorticoide/antagonistas & inibidores , Masculino , Camundongos , Células Mieloides/parasitologia , Gravidez , Linfócitos T Reguladores/parasitologia , Toxoplasmose/tratamento farmacológicoRESUMO
Anti-CD20 depletion therapies targeting B cells are commonly used in malignant B cell disease and autoimmune diseases. There are concerns about the ability of B cells to respond to infectious diseases acquired either before or after B cell depletion. There is evidence that the B cell response to existing or acquired viral infections is compromised during treatment, as well as the antibody response to vaccination. Our laboratory has an experimental system using co-infection of C3H mice with both Leishmania major and Leishmania amazonensis that suggests that the B cell response is important to healing infected mice. We tested if anti-CD20 treatment would completely restrict the B cell response to these intracellular pathogens. Infected mice that received anti-CD20 B cell depletion therapy had a significant decrease in CD19(+) cells within their lymph nodes and spleens. However, splenic B cells were detected in depleted mice and an antigen-specific antibody response was produced. These results indicate that an antigen-specific B cell response towards intracellular pathogens can be generated during anti-CD20 depletion therapy.